Skip to main content

and
  1. Article

    Open Access

    Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report

    Patients with ovarian clear cell carcinoma (OCCC) have a poor prognosis because they show low sensitivity to platinum-based chemotherapy. New treatments for refractory OCCC are urgently needed.

    Yu-Chien Lin, Kuo-Chang Wen, Pi-Lin Sung, Yu-Ting Chou in Journal of Ovarian Research (2020)

  2. Article

    Open Access

    Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer

    Ovarian cancer is the leading cause of cancer-related death among women. Complete cytoreductive surgery followed by platinum-taxene chemotherapy has been the gold standard for a long time. Various compounds ha...

    Kuo-Chang Wen, Pi-Lin Sung, Alexander T. H. Wu in Journal of Ovarian Research (2020)